Investigating Alzheimer's disease in patients with HIV
Official title: NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease
Funded at University of Texas Med Br Galveston · NIH-11217625 · Data updated 2026-11-12
This study is looking at how Alzheimer's disease and brain issues related to HIV affect each other, and it's for people who have both conditions; by studying tissue samples, researchers hope to find better ways to help improve brain health for these individuals.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project start | August 23, 2023 |
| Project end | August 22, 2025 |
| Funding year | 2024 |
| Award (this year) | $316,467 |
| NIH project number | 75N95023C00016-P00002-9999-2 |
| Project ID | NIH-11217625 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who also have a history of HIV infection.
✕Less likely to help
Patients who do not have Alzheimer's disease or HIV are unlikely to benefit from this research.
What this research studies
This research focuses on understanding the relationship between Alzheimer's disease and HIV-associated neurological disorders. It aims to collect and analyze tissue samples from patients to explore how these conditions interact and affect brain health. By examining these samples, researchers hope to uncover insights that could lead to improved treatment strategies for individuals suffering from both Alzheimer's and HIV-related cognitive impairments.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients with Alzheimer's disease who are also living with HIV.
How similar studies have gone: Previous research has shown promising results in understanding the interplay between neurodegenerative diseases and HIV, indicating that this approach has potential for significant findings.
Where this research is happening
-
University of Texas Med Br Galveston
Galveston, United States Active
Researchers
- Principal investigator: Gelman, Benjamin — University of Texas Med Br Galveston
- Study coordinator: Gelman, Benjamin
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.